Urinary Ba May Be Biomarker, Mediator Of AKI In Critically Ill Patients, Research Suggests

Renal & Urology News (1/2, Persaud) reported, “Urinary Ba, a fragment of complement factor B, may be a biomarker and mediator of acute kidney injury (AKI) in critically ill patients, investigators suggest.” In an “analysis of the EARLYARF randomized trial, investigators compared 124, 43, and 20 critically ill adults with KDIGO stage 1, 2, and 3 AKI, respectively, and 252 patients without AKI.” Researchers found that “urine Ba significantly increased along with AKI stage.” The findings were published in Kidney International Reports.